425 related articles for article (PubMed ID: 32510745)
1. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
Xu Z; Li Y; Li M; Xiang H; Yan A
Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
[TBL] [Abstract][Full Text] [Related]
2. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
[TBL] [Abstract][Full Text] [Related]
3. Endogenous CRISPR-Cas mediated in situ genome editing: State-of-the-art and the road ahead for engineering prokaryotes.
Liu Z; Liu J; Yang Z; Zhu L; Zhu Z; Huang H; Jiang L
Biotechnol Adv; 2023 Nov; 68():108241. PubMed ID: 37633620
[TBL] [Abstract][Full Text] [Related]
4. Characterization and applications of Type I CRISPR-Cas systems.
Hidalgo-Cantabrana C; Barrangou R
Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
[TBL] [Abstract][Full Text] [Related]
5. Application of different types of CRISPR/Cas-based systems in bacteria.
Liu Z; Dong H; Cui Y; Cong L; Zhang D
Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
[TBL] [Abstract][Full Text] [Related]
6. Multiplex genome editing of microorganisms using CRISPR-Cas.
Adiego-Pérez B; Randazzo P; Daran JM; Verwaal R; Roubos JA; Daran-Lapujade P; van der Oost J
FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31087001
[TBL] [Abstract][Full Text] [Related]
7. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
8. Genome Editing in Bacteria: CRISPR-Cas and Beyond.
Arroyo-Olarte RD; Bravo Rodríguez R; Morales-Ríos E
Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33920749
[TBL] [Abstract][Full Text] [Related]
9. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas immunity, DNA repair and genome stability.
Cubbon A; Ivancic-Bace I; Bolt EL
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
Koonin EV; Gootenberg JS; Abudayyeh OO
Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
[TBL] [Abstract][Full Text] [Related]
12. Diversity and evolution of class 2 CRISPR-Cas systems.
Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
Khanzadi MN; Khan AA
J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
[TBL] [Abstract][Full Text] [Related]
15. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering.
Zheng Y; Li J; Wang B; Han J; Hao Y; Wang S; Ma X; Yang S; Ma L; Yi L; Peng W
Front Bioeng Biotechnol; 2020; 8():62. PubMed ID: 32195227
[TBL] [Abstract][Full Text] [Related]
17. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas genome editing systems in thermophiles: Current status, associated challenges, and future perspectives.
Le Y; Sun J
Adv Appl Microbiol; 2022; 118():1-30. PubMed ID: 35461662
[TBL] [Abstract][Full Text] [Related]
19. [Application and optimization of CRISPR/Cas system in bacteria].
Fu J; Yang F; Xie H; Gu F
Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
[TBL] [Abstract][Full Text] [Related]
20. Emergent CRISPR-Cas-based technologies for engineering non-model bacteria.
Volke DC; Orsi E; Nikel PI
Curr Opin Microbiol; 2023 Oct; 75():102353. PubMed ID: 37413959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
